
CAS: 78659-11-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | hCAI/II/IV-IN-28 REF: 54-BUP04092CAS: 78659-11-7 | 96.47% | 1,377.00 €~4,550.00 € | Thu 17 Apr 25 |
![]() | hCAI/II/IV-IN-28 REF: TM-T80663CAS: 78659-11-7 | 96.48% | 185.00 €~1,833.00 € | Thu 17 Apr 25 |

Ref: 54-BUP04092
25mg | 1,377.00 € | ||
50mg | 1,839.00 € | ||
100mg | 2,482.00 € | ||
500mg | 4,550.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025

hCAI/II/IV-IN-28
CAS:78659-11-7
hCAI/II/IV-IN-28(WAY-638358) is a potent carbonic anhydrase inhibitor with potential anticonvulsant activity.
Formula:
C14H15N3O3S
Purity:
96.48%
Color and Shape:
Liquid
Molecular weight:
305.35
Ref: TM-T80663
1mg | 185.00 € | ||
5mg | 442.00 € | ||
10mg | 645.00 € | ||
25mg | 1,017.00 € | ||
50mg | 1,359.00 € | ||
100mg | 1,833.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025